To dispel the possibility the observed differential expression of LOXL1 was due to differences in tumor purity, ILC versus non‐ILC, the cellular composition of the tumor microenvironment was adjusted for (Aran et al, 2017). The gene discussed is LOXL1; the disease is neoplasm.